Follow
Filippo Pinto e Vairo
Filippo Pinto e Vairo
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Maple syrup urine disease: mechanisms and management
PR Blackburn, JM Gass, FPE Vairo, KM Farnham, HK Atwal, S Macklin, ...
The application of clinical genetics, 57-66, 2017
2002017
De novo pathogenic variants in CACNA1E cause developmental and epileptic encephalopathy with contractures, macrocephaly, and dyskinesias
KL Helbig, RJ Lauerer, JC Bahr, IA Souza, CT Myers, B Uysal, N Schwarz, ...
The American Journal of Human Genetics 103 (5), 666-678, 2018
1112018
A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia
SE Flanagan, F Vairo, MB Johnson, R Caswell, TW Laver, H Lango Allen, ...
Pediatric diabetes 18 (4), 320-323, 2017
892017
Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis
T Alegra, F Vairo, MV de Souza, BC Krug, IVD Schwartz
Genetics and molecular biology 35, 947-954, 2012
812012
A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease
FP e Vairo, BC Chwal, S Perini, MAP Ferreira, AC de Freitas Lopes, ...
Molecular genetics and metabolism 126 (1), 6-13, 2019
772019
Diagnostic and treatment strategies in mucopolysaccharidosis VI
F Vairo, A Federhen, G Baldo, M Riegel, M Burin, S Leistner-Segal, ...
The application of clinical genetics, 245-255, 2015
752015
Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy
DC Pant, I Dorboz, A Schluter, S Fourcade, N Launay, J Joya, ...
The Journal of clinical investigation 129 (3), 1240-1256, 2019
692019
Phenylketonuria and gut microbiota: a controlled study based on next-generation sequencing
F Pinheiro de Oliveira, RH Mendes, PT Dobbler, V Mai, VS Pylro, ...
PLoS One 11 (6), e0157513, 2016
662016
Emerging drugs for the treatment of mucopolysaccharidoses
R Giugliani, A Federhen, F Vairo, C Vanzella, G Pasqualim, LMR Da Silva, ...
Expert opinion on emerging drugs 21 (1), 9-26, 2016
652016
Lysosomal diseases: Overview on current diagnosis and treatment
FO Poswar, F Vairo, M Burin, K Michelin-Tirelli, AC Brusius-Facchin, ...
Genetics and molecular biology 42, 165-177, 2019
562019
Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know
R Reichert, LG Campos, F Vairo, CFM de Souza, JA Pérez, JÁ Duarte, ...
Radiographics 36 (5), 1448-1462, 2016
532016
Analysis of LMNB1 Duplications in Autosomal Dominant Leukodystrophy Provides Insights into Duplication Mechanisms and Allele‐Specific Expression
E Giorgio, H Rolyan, L Kropp, AB Chakka, S Yatsenko, ED Gregorio, ...
Human mutation 34 (8), 1160-1171, 2013
492013
Mucopolysaccharidosis type I
F Kubaski, F de Oliveira Poswar, K Michelin-Tirelli, US Matte, DD Horovitz, ...
Diagnostics 10 (3), 161, 2020
462020
Partial loss of USP9X function leads to a male neurodevelopmental and behavioral disorder converging on transforming growth factor β signaling
BV Johnson, R Kumar, S Oishi, S Alexander, M Kasherman, MS Vega, ...
Biological psychiatry 87 (2), 100-112, 2020
452020
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS
R Giugliani, F Vairo, F Kubaski, F Poswar, M Riegel, G Baldo, JA Saute
The Lancet Child & Adolescent Health 2 (1), 56-68, 2018
442018
Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis
AD Dornelles, O Artigalás, AA Da Silva, DLV Ardila, T Alegra, TV Pereira, ...
PLoS One 12 (8), e0184065, 2017
402017
Genotypic and phenotypic characterization of Brazilian patients with GM1 gangliosidosis
F Sperb, F Vairo, M Burin, FQ Mayer, U Matte, R Giugliani
Gene 512 (1), 113-116, 2013
392013
Biomolecules damage and redox status abnormalities in Fabry patients before and during enzyme replacement therapy
GB Biancini, CE Jacques, T Hammerschmidt, HM de Souza, B Donida, ...
Clinica Chimica Acta 461, 41-46, 2016
352016
Impact of integrated translational research on clinical exome sequencing
EW Klee, MA Cousin, F Pinto e Vairo, JA Morales-Rosado, EL Macke, ...
Genetics in Medicine 23 (3), 498-507, 2021
332021
Living related versus deceased donor liver transplantation for maple syrup urine disease
F Feier, IVD Schwartz, AR Benkert, JS Neto, I Miura, P Chapchap, ...
Molecular genetics and metabolism 117 (3), 336-343, 2016
332016
The system can't perform the operation now. Try again later.
Articles 1–20